Arena Pharmaceuticals Inc (NASDAQ:ARNA)

48.89
Delayed Data
As of Jun 18
 -0.58 / -1.17%
Today’s Change
12.51
Today|||52-Week Range
49.85
+43.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-60.5M-108.0M-22.1M-90.1M
 
 
 
 
 
Depreciation9.2M10.0M9.4M4.3M
 
 
 
 
 
Total Other Cash Flow-40.2M15.1M33.5M11.0M
 
 
 
 
 
Funds From Operations-91.5M-82.8M20.7M-74.8M
 
 
 
 
 
Funds From/For Other Operating Expenses9.9M15.3M82.9M-8.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-101.4M-98.1M-62.1M-66.6M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-112.6M
 
 
Capital Expenditures-8.9M-11.0M-950.0K-113.0K
 
 
 
 
 
Fixed Asset Disposal47.0K2.2M954.0K789.0K
 
 
 
 
 
Other Investing - Uses--0.000.00-446.0K
 
 
Other Investing - Sources49.8M609.0K----
 
 
 
Net Cash Flow Investing40.9M-8.2M-750.0K-112.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-2.1M-2.5M-3.0M-3.5M
 
 
 
 
 
Net Proceeds Stock Sale5.2M103.6M370.0K248.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.00320.0K0.00
 
 
Other Uses - Financing0.000.00--0.00--
Net Cash Flow - Financing3.2M101.1M-2.3M245.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.3M-1.9M-294.0K1.9M
 
 
 
 
 
 
Net Change In Cash-57.3M-5.1M-65.2M66.3M